Let’s create
life-changing
value
Bloodworks Research Institute is a national leader in blood-based innovation, home to world-class researchers and innovators. We currently manage a large portfolio of potentially lifesaving technologies, including devices and therapeutics. We are always looking for new and creative partnerships that will bring these scientific discoveries to market.
Magnify the Power of Discovery
Our scientists continually invent new tools, technologies, and innovations in the course of their blood research. Many of these amazing discoveries could also benefit a broader audience – from researchers to industry to patients.
Through Intellectual Property (IP) licensing and R&D partnership agreements, we work with our investment partners to develop successful commercial markets for the latest advances in blood science.
Partnership with Bloodworks Bio offers:
- Valuable intellectual property primed for introduction to a wider market
- Opportunities to commercialize lifesaving innovations
- Cost- and time-savings over in-house R&D programs
- Full portfolio of products and services, expert medical staff, infrastructure, systems, and facilities ready to go
Find an Investment Opportunity
Seeking prototype development partners
Summary
Compositions and methods useful for point of care testing for hemophilia by measuring coagulation factor levels.
Type
In Vitro Diagnostic
Seeking collaborative R&D partners
Summary
Compositions and methods for determining the level of thiol and disulfide containing molecules in a sample, which can be used to determine the level of oxidative stress in a subject with or without antioxidant treatment.
Type
In Vitro Diagnostic
Seeking collaborative R&D partners
Summary
Methods for diagnosing ADAMTS13-associated disorders and methods for providing improved treatment of those disorders by evaluating the efficacy of the treatment using the methods.
Type
In Vitro Diagnostic
Ready for licensing
Summary
Compositions and methods of using antibodies that are able to recognize single amino acid polymorphisms in a protein which may be used for blood typing or to block hemolytic transfusion reactions and/or hemolytic disease of the fetus and newborn.
Type
Innovations in Blood Screening/Testing
Ready for licensing for further R&D
Summary
Compositions and related methods for using RBCs from transgenic mice expressing human antigens for detection of human alloantibodies.
Type
Innovations in Blood Screening/Testing
Ready for licensing
Summary
Bloodworks has created a humanized monoclonal antibody pan-reactive for HLA Class I that can serve as an effective control for HLA expression level in HLA crossmatching and antibody assays. This technology will allow for standardization of HLA assays across runs and amongst different clinical laboratories.'
Type
Innovations in Blood Screening/Testing
Ready for licensing
Summary
Compositions and methods which are useful for determining the sensitivity and specificity of antibody detection reagents.
Type
Innovations in Blood Screening/Testing
Ready for licensing
Summary
Methods, systems, mediums, and kits for use in phenotyping antibody responses via devices such as surface plasmon resonance devices.
Type
Innovations in Blood Screening/Testing
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival of platelets and the suitability of platelet units for transfusion by measuring the levels of one or more markers in a platelet sample.
Type
Innovations in Platelet Storage
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival of platelets and the suitability of platelet units for transfusion by measuring the levels of one or more markers in a platelet sample.
Type
Innovations in Platelet Storage
Seeking collaborative R&D partners
Summary
Methods to significantly reduce clot formation in cold-stored platelet samples.
Type
Innovations in Platelet Storage
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more markers in a RBC sample.
Type
Innovations in Red Blood Cell Storage
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more markers in a RBC sample.
Type
Innovations in Red Blood Cell Storage
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more markers in a RBC sample.
Type
Innovations in Red Blood Cell Storage
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more markers in a RBC sample.
Type
Innovations in Red Blood Cell Storage
Seeking collaborative R&D partners
Summary
Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more markers in a RBC sample.
Type
Innovations in Red Blood Cell Storage
Ready for licensing
Summary
Biomarkers and methods for identifying subjects at risk of developing cytokine release syndrome (CRS), neurotoxicity, or both after adoptive immunotherapy to guide preemptive intervention, modified therapy, or the like.
Type
Prognostic
Seeking collaborative R&D partners
Summary
A transgenic mouse with modified glucose-6-phosphate dehydrogenase which can be used as a model and screening tool for various aspects of glucose-6-phosphate dehydrogenase deficiency.
Type
Research Tool
Ready for licensing
Summary
Compositions and methods for making monoclonal antibodies specific for single amino acid variation in an antigen.
Type
Research Tool
Seeking collaborative R&D partners
Summary
Compositions and methods for the induction of tolerance using recombinant cell surface antigens in a vertebrate subject.
Type
Therapeutic
Seeking collaborative R&D partners
Summary
Methods and compositions to modify donor whole blood or platelets prior to transfusion to prevent or reduce platelet transfusion associated complications.
Type
Therapeutic
Seeking collaborative R&D partners
Summary
Methods and compositions for suppressing an immune response to Factor VIII in subjects suffering from hemophilia A and having preformed inhibitor antibodies against Factor VIII, and compositions and methods that advantageously render subjects amenable to standard treatments for hemophilia A.
Type
Therapeutic
Seeking collaborative R&D partners
Summary
Compositions and methods for: (1) preventing or reducing protein loss due to protein aggregation, denaturation, and absorption to surfaces; (2) preventing or reducing the fouling or clogging of medical devices that come into contact with blood; (3) treating diseases caused by activation of the microvasculature.
Type
Therapeutic